Document Detail


Risk factor profile and achievement of treatment goals among hypertensive patients from the Israeli Blood Pressure Control (IBPC) program--initial cost utility analysis.
MedLine Citation:
PMID:  14596359     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: Blood pressure (BP) reduction is crucial in reducing cardiovascular morbidity and mortality. The IBPC (Israeli Blood Pressure Control) program was initiated in order to enhance the control of modifiable risk factors among high-risk hypertensive patients under follow-up by general practitioners in Israel. The cost effectiveness of an intervention program is an important factor in the decision-making process of its implementation and therefore was evaluated here. The objective of this evaluation is to estimate the costs, monetary savings and benefits in terms of QALYs (quality-adjusted life years) that would be expected if the program were to be expanded to 100 clinics nationwide, enabling around 14800 persons to be treated. METHODS: Hypertensive patients were screened in 30 general practice clinics, supervised by specialists in family medicine, each seeing 1000-5000 patients; 50-250 hypertensive patients were diagnosed at each participating clinic. BP levels, body mass index (BMI), lipid and glucose levels, as well as target organ damage and medications were recorded for all patients. RESULTS: A total of 4948 (2079, 42% males) were registered. Mean age was 64.8 +/- 12 years. After 1 year of follow-up versus baseline, the various parameters were as follows: BP control was achieved in 46.4% vs 29% of all hypertensive patients. LDL control (JNC VI criteria) was achieved in 41.7% vs 31.2% of all patients. Fasting plasma glucose control (glucose < 126 mg/dl) was achieved in 22% vs 19% of diabetic patients and 5.2% vs 3.1% of the diabetics had fasting plasma glucose levels > 200 mg/dl. Obesity (BMI > 30 kg/m2) was noted in 36.7% vs 43.8% at baseline. The cost utility analysis of the reduction in risk factors was calculated based on the international dicta applied to the reduction in risk factors as a result of treatment. For 100 clinics nationwide and 14800 persons to be treated the net saving to health services would be $977993 and the increase in QALYs would be 602 years. CONCLUSIONS: Better risk factor control in hypertensive patients by general practitioners could reduce morbidity and mortality as well as be cost effective.
Authors:
C Yosefy; G M Ginsberg; D Dicker; J R Viskoper; T H Tulchinsky; E Leibovitz; D Gavish;
Related Documents :
2006659 - Adverse treatment effects in the trial of the european working party on high blood pres...
3098789 - Utility and limitations of splanchnic venous ultrasonography in diagnosis of portal hyp...
1178809 - The haemolytic uraemic syndrome--a family study.
7069999 - Abnormal relationship between sodium intake and sympathetic nervous system activity in ...
2794079 - Gastric mucosa in patients with portal hypertension: prevalence of capillary dilatation...
20412469 - Clevidipine for severe hypertension in acute heart failure: a velocity trial analysis.
20309409 - Effect of educational level on oral health in peritoneal and hemodialysis patients.
3489109 - Organ failures due to low cardiac output syndrome following open heart surgery.
825099 - The significance of some noninvasive methods in the objective evaluation of treatment o...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Blood pressure     Volume:  12     ISSN:  0803-7051     ISO Abbreviation:  Blood Press.     Publication Date:  2003  
Date Detail:
Created Date:  2003-11-04     Completed Date:  2004-06-09     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9301454     Medline TA:  Blood Press     Country:  Norway    
Other Details:
Languages:  eng     Pagination:  225-31     Citation Subset:  IM    
Affiliation:
WHO Collaborative Center for Prevention and Treatment of Cardiovascular Disease, Barzilai Medical Center Campus, Ben-Gurion University of the Negev, Ashkelon, Israel. yosefy@barzi.health.gov.il
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Blood Glucose
Blood Pressure / physiology*
Body Mass Index
Cholesterol, HDL / blood
Cholesterol, LDL / blood
Cost-Benefit Analysis
Family Practice / economics,  education
Female
Follow-Up Studies
Health Care Costs / statistics & numerical data
Humans
Hypertension / epidemiology,  physiopathology,  prevention & control*
Israel / epidemiology
Male
Mass Screening / economics,  methods
Middle Aged
Myocardial Infarction / epidemiology,  prevention & control
Obesity / diagnosis
Patient Selection
Prevalence
Quality-Adjusted Life Years
Risk Factors
Stroke / epidemiology,  prevention & control
Treatment Outcome
Triglycerides / blood
Chemical
Reg. No./Substance:
0/Blood Glucose; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Triglycerides

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Interest of home blood pressure measurements (HBPM) to establish degree of hypertensive control.
Next Document:  Effectiveness of hypertension treatment assessed by blood pressure level achieved in primary care se...